vs
Side-by-side financial comparison of FirstCash Holdings, Inc. (FCFS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
FirstCash Holdings, Inc. is the larger business by last-quarter revenue ($501.3M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). FirstCash Holdings, Inc. runs the higher net margin — 20.8% vs 6.8%, a 14.0% gap on every dollar of revenue. On growth, FirstCash Holdings, Inc. posted the faster year-over-year revenue change (21.2% vs -1.7%). Over the past eight quarters, FirstCash Holdings, Inc.'s revenue compounded faster (16.9% CAGR vs -0.1%).
FirstCash Holdings, Inc. is an American pawnshop company headquartered in Fort Worth, Texas which operates retail pawn stores in the U.S. and Latin America. It is a publicly traded company listed on the Nasdaq stock exchange.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FCFS vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $501.3M | $493.8M |
| Net Profit | $104.2M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 28.5% | 9.9% |
| Net Margin | 20.8% | 6.8% |
| Revenue YoY | 21.2% | -1.7% |
| Net Profit YoY | 24.7% | 10.5% |
| EPS (diluted) | $2.35 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $501.3M | $493.8M | ||
| Q3 25 | $411.0M | $492.9M | ||
| Q2 25 | $385.1M | $468.8M | ||
| Q1 25 | $371.1M | $458.4M | ||
| Q4 24 | $413.7M | $502.4M | ||
| Q3 24 | $363.1M | $511.2M | ||
| Q2 24 | $363.5M | $504.3M | ||
| Q1 24 | $366.8M | $495.1M |
| Q4 25 | $104.2M | $33.7M | ||
| Q3 25 | $82.8M | $71.7M | ||
| Q2 25 | $59.8M | $39.3M | ||
| Q1 25 | $83.6M | $20.7M | ||
| Q4 24 | $83.5M | $30.5M | ||
| Q3 24 | $64.8M | $19.4M | ||
| Q2 24 | $49.1M | $-153.0M | ||
| Q1 24 | $61.4M | $4.0M |
| Q4 25 | 28.5% | 9.9% | ||
| Q3 25 | 27.4% | 13.8% | ||
| Q2 25 | 21.1% | 12.8% | ||
| Q1 25 | 30.0% | 7.0% | ||
| Q4 24 | 26.5% | 7.8% | ||
| Q3 24 | 23.5% | 6.6% | ||
| Q2 24 | 18.2% | -31.3% | ||
| Q1 24 | 22.3% | 3.2% |
| Q4 25 | 20.8% | 6.8% | ||
| Q3 25 | 20.1% | 14.5% | ||
| Q2 25 | 15.5% | 8.4% | ||
| Q1 25 | 22.5% | 4.5% | ||
| Q4 24 | 20.2% | 6.1% | ||
| Q3 24 | 17.9% | 3.8% | ||
| Q2 24 | 13.5% | -30.3% | ||
| Q1 24 | 16.7% | 0.8% |
| Q4 25 | $2.35 | $0.40 | ||
| Q3 25 | $1.86 | $0.84 | ||
| Q2 25 | $1.34 | $0.46 | ||
| Q1 25 | $1.87 | $0.24 | ||
| Q4 24 | $1.86 | $0.37 | ||
| Q3 24 | $1.44 | $0.23 | ||
| Q2 24 | $1.08 | $-1.84 | ||
| Q1 24 | $1.35 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.2M | $375.2M |
| Total DebtLower is stronger | $2.2B | $570.5M |
| Stockholders' EquityBook value | $2.3B | $865.9M |
| Total Assets | $5.3B | $2.2B |
| Debt / EquityLower = less leverage | 0.98× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.2M | $375.2M | ||
| Q3 25 | $130.2M | $340.1M | ||
| Q2 25 | $101.5M | $224.7M | ||
| Q1 25 | $146.0M | $99.0M | ||
| Q4 24 | $175.1M | $229.9M | ||
| Q3 24 | $106.3M | $103.8M | ||
| Q2 24 | $113.7M | $19.4M | ||
| Q1 24 | $135.1M | $8.0M |
| Q4 25 | $2.2B | $570.5M | ||
| Q3 25 | $2.2B | $577.2M | ||
| Q2 25 | $1.7B | $583.9M | ||
| Q1 25 | $1.7B | $590.5M | ||
| Q4 24 | $1.7B | $597.1M | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $2.3B | $865.9M | ||
| Q3 25 | $2.2B | $890.7M | ||
| Q2 25 | $2.1B | $833.8M | ||
| Q1 25 | $2.1B | $789.2M | ||
| Q4 24 | $2.1B | $764.9M | ||
| Q3 24 | $2.0B | $732.5M | ||
| Q2 24 | $2.0B | $706.5M | ||
| Q1 24 | $2.0B | $856.2M |
| Q4 25 | $5.3B | $2.2B | ||
| Q3 25 | $5.2B | $2.2B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.4B | $2.0B | ||
| Q4 24 | $4.5B | $2.2B | ||
| Q3 24 | $4.4B | $2.1B | ||
| Q2 24 | $4.3B | $2.0B | ||
| Q1 24 | $4.2B | $2.2B |
| Q4 25 | 0.98× | 0.66× | ||
| Q3 25 | 1.01× | 0.65× | ||
| Q2 25 | 0.79× | 0.70× | ||
| Q1 25 | 0.83× | 0.75× | ||
| Q4 24 | 0.85× | 0.78× | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $206.6M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.98× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.6M | $114.1M | ||
| Q3 25 | $135.8M | $137.3M | ||
| Q2 25 | $116.9M | $137.2M | ||
| Q1 25 | $126.6M | $-117.5M | ||
| Q4 24 | $198.1M | $133.0M | ||
| Q3 24 | $113.1M | $91.8M | ||
| Q2 24 | $106.2M | $107.0M | ||
| Q1 24 | $122.5M | $-125.2M |
| Q4 25 | 1.98× | 3.39× | ||
| Q3 25 | 1.64× | 1.91× | ||
| Q2 25 | 1.95× | 3.49× | ||
| Q1 25 | 1.51× | -5.66× | ||
| Q4 24 | 2.37× | 4.36× | ||
| Q3 24 | 1.74× | 4.72× | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 2.00× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |